US2014171630A1PendingUtilityA1

Novel synthesis of galactoside inhibitors

58
Assignee: GALECTO BIOTECH ABPriority: May 16, 2008Filed: Feb 20, 2014Published: Jun 19, 2014
Est. expiryMay 16, 2028(~1.8 yrs left)· nominal 20-yr term from priority
Inventors:Ulf Nilsson
C07H 5/10A61P 35/00A61P 31/00A61P 29/00C07H 19/056
58
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Novel synthesis routes for preparation of thiodigalactosides and intermediates are presented. The method includes the use of a 3-azido-galactosyl thiouronium salt derivative, which is activated to the corresponding thiol in situ, which in turn is directly reacted with a 3-azido-galactosyl bromide resulting in the 3,3′-di-azido-thio-di-galactoside before the thiol has a chance to reduce the azido 10 group. Hence, in situ formation of the 3-azido-galactosyl thiol from the thiouronium salt is essential in the synthesis procedure, because any other method that generate the thiol separately results in extensive unwanted azide reduction.

Claims

exact text as granted — not AI-modified
1 . A compound of the formula (14) 
       
         
           
           
               
               
           
         
       
       wherein R is one or more trifluoromethyl, preferably in meta and/or para position. 
     
     
         2 . The compound of  claim 1  wherein R is one trifluoromethyl. 
     
     
         3 . The compound of  claim 1  wherein R is two trifluoromethyl. 
     
     
         4 . The compound of  claim 2  wherein R is in meta position. 
     
     
         5 . The compound of  claim 2  wherein R is in para position. 
     
     
         6 . The compound of  claim 3  wherein R is in meta and para position.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.